CTOs on the Move

Metamark

www.metamarkgenetics.com

 
Metamark Genetics, Inc. is a privately held biotechnology company founded in 2007 to develop novel, function-based, prognostic and diagnostic tests aimed at improving cancer care. The company's proprietary genomic and proteomic discovery platforms have yielded significant discoveries in several disease areas, including prostate, colon, and breast cancers. In early 2014, Metamark plans to commercialize ProMark™—its prostate cancer prognostic test—through its Cambridge, Massachusetts CLIA-certified laboratory. For more information, please visit the company's Website at www.metamarkgenetics.com. Metamark™ and ProMark™ are trademarks of Metamark Genetics, Inc.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

Lifeblood Mid South Regional Blood Center

Lifeblood opens the East Donor Center on Estate Drive. In 1954, another proposal to establish a blood center in Memphis was rejected for the same reason-it was too costly. Finally in 1962, the Committee on Blood Bank Operation of the Memphis and Shelby

That Touch Of Class

That Touch Of Class is a Caro, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Americana Dental Inc

Americana Dental Inc is a Tampa, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nicoya

Nicoya is a Canadian biotechnology company dedicated to improving human life by helping scientists succeed. Established in 2012, Nicoya develops innovative and accessible biosensor technology for in-depth characterization of biomolecular interactions. ...

NarrativeDx

NarrativeDx is the artificial intelligence platform for patient experience. Our SaaS platform is the market leader in transforming hospitals` clinical outcomes by extracting data trends and gaining visibility into the patient experience. We help hospital leaders and care providers understand and improve their institution`s patient experience, drive patient referrals, increase hospital revenue, and boost hospital reputations.